1. H. Nakanishi, K. Irie, K. Segawa, K, Hasegawa, Y. Fujiyoshi, S. Nagata and K. Abe. Crystal structure of a human plasma membrane phospholipid flippase. J. Biol. Chem, 2020, 295, 10180-10194, doi: 10.1074/jbc.RA120.014144.
2. H. Nakanishi, T. Nishizawa, K. Segawa, O. Nureki, Y. Fujiyoshi, S. Nagata and K. Abe. Transport cycle of plasma membrane flippase ATP11C by cryo-EM. Cell Reports, 2020, 32, 108208, doi: 10.1016/j.celrep.2020.108208.
3. Structural equilibrium underlying ligand-dependent activation of β2-adrenoreceptor Imai S, Yokomizo T, Kofuku Y, Shiraishi Y, Ueda T, and Shimada I. Nat. Chem. Biol. (2020) 16, 430-439. DOI: 10.1038/s41589-019-0457-5.
4. Structural fingerprints of an intact monoclonal antibody acquired by 15N-detected solution NMR experiments under the formulated storage conditions. Tokunaga Y, Takeuchi K, Okude J, Ori K, Torizawa T, and Shimada I. J Med. Chem. (2020) 63, 5360-5366. doi: 10.1021/acs.jmedchem.0c00231.
5. Targeting the cryptic sites: NMR-based strategy to improve protein druggability by controlling the conformational equilibrium Mizukoshi Y, Takeuchi K, Tokunaga Y, Matsuo H, Imai M, Fujisaki M, Kamoshida H, Takizawa T, Hanzawa H, and Shimada I. Sci. Adv. (2020) 6, eabd0480. DOI: 10.1126/sciadv.abd0480
6. Real-time In-cell NMR Reveals the Intracellular Modulation of GTP-bound Levels of RAS Zhao Q, Fujimiya R, Kubo S, Marshall CB, Ikura M, Shimada I, Nishida N. Cell Rep. (2020) 32, 108074. DOI: 10.1016/j.celrep.2020.108074
7. Conformational equilibrium shift underlies altered K+ channel gating as revealed by NMR Iwahashi Y, Toyama Y, Imai S, Itoh H, Osawa M, Inoue M, and Shimada I. Nat. Commun. (2020) 11, 5168. Doi: 10.1038/s41467-020-19005-3.
8. Mechanism of hERG inhibition by gating-modifier toxin, APETx1, deduced by functional characterization. Matsumura K, Shimomura T, Kubo Y, Oka T, Kobayashi N, Imai S, Yanase N, Akimoto M, Fukuda M, Yokogawa M, Ikeda K, Kurita JI, Nishimura Y, Shimada I, Osawa M. BMC Mol. Cell Biol. (2021) 22, 3.
9. Conformational Plasticity of Cyclic Ras-Inhibitor Peptides Defines Cell Permeabilization Activity.Takeuchi K, Misaki I, Tokunaga Y, Fujisaki M, Kamoshida H, Takizawa T, Hanzawa H, Shimada I.Angew. Chem. Int. Ed. (2021) 60, 6567-6572
10. S. Iida, H. K. Nakamura, T. Mashimo, Y. Fukunishi. Structural Fluctuations of Aromatic Residues in an Apo-Form Reveal Cryptic Binding Sites: Implications for Fragment-based Drug Design". J. Phys. Chem. B, 124, 45, 9977-9986 (2020). DOI: 10.1021/acs.jpcb.0c04963."